This content is restricted.
Brief
"On Wednesday, 6 August, the Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care Excellence (NICE) announced plans to streamline medicines access in the NHS. Under a joint information sharing agreement, pharmaceutical companies will register early with both agencies, allowing parallel decision making over licensing and value, which is expected to result in patients receiving newer medicines 3-6 months earlier."
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested